Clinical Trial Update: Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating temsirolimus with bendamustine and rituximab in relapsed follicular lymphoma or mantle cell lymphoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: Georg Hess, MD | Conditions: Follicular Lymphoma, Mantle Cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED